Fennec Pharmaceuticals (FENC) Change in Receivables (2023 - 2025)
Fennec Pharmaceuticals posted quarterly Change in Receivables of $3.5 million for Q4 2025, up 1876.0% year-on-year from $175000.0 in Q4 2024, and up 0.52% on a QoQ basis from $3.4 million in Q3 2025.
Fennec Pharmaceuticals (FENC) has 3 years of Change in Receivables data on file, last reported at $3.5 million in Q4 2025.
- For the quarter ending Q4 2025, Change in Receivables rose 1876.0% year-over-year to $3.5 million; the trailing twelve-month figure through Dec 2025 stood at $12.4 million (up 58.01% YoY), and the FY2025 full-year result was $12.4 million, up 58.01% from the prior year.
- Change in Receivables for Q4 2025 stood at $3.5 million, up from $3.4 million in the prior quarter.
- Across five years, Change in Receivables topped out at $5.3 million in Q1 2025 and bottomed at $138000.0 in Q1 2023.
- The 3-year median for Change in Receivables is $2.1 million (2023), against an average of $2.3 million.
- The widest annual swing landed in 2024, when Change in Receivables sank 95.92%; it then soared 1876.0% in 2025.
- A 3-year view of Change in Receivables shows it stood at $4.3 million in 2023, then tumbled by 95.92% to $175000.0 in 2024, then jumped by 1876.0% to $3.5 million in 2025.
- The last three Change in Receivables figures came in at $3.5 million (Q4 2025), $3.4 million (Q3 2025), and $265000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 208,524.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -39.80 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -1.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 110.42 Mn |
| 10 | Fennec Pharmaceuticals | 281.48 Mn | 244.70 Mn | 7.67 Mn | 3.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.46 Mn |
| Dec 31, 2025 | 3.46 Mn |
| Sep 30, 2025 | 3.44 Mn |
| Sep 30, 2025 | 3.44 Mn |
| Jun 30, 2025 | 265,000.00 |
| Jun 30, 2025 | 265,000.00 |
| Mar 31, 2025 | 5.28 Mn |
| Mar 31, 2025 | 5.28 Mn |
| Dec 31, 2024 | 175,000.00 |
| Dec 31, 2024 | 175,000.00 |
| Sep 30, 2024 | 4.20 Mn |
| Sep 30, 2024 | 4.20 Mn |
| Jun 30, 2024 | 2.04 Mn |
| Jun 30, 2024 | 2.04 Mn |
| Mar 31, 2024 | 1.46 Mn |
| Mar 31, 2024 | 1.46 Mn |
| Dec 31, 2023 | 4.29 Mn |
| Dec 31, 2023 | 4.29 Mn |
| Sep 30, 2023 | 2.08 Mn |
| Sep 30, 2023 | 2.08 Mn |
| Jun 30, 2023 | 762,000.00 |
| Jun 30, 2023 | 762,000.00 |
| Mar 31, 2023 | 138,000.00 |
| Mar 31, 2023 | 138,000.00 |